Carbapenem resistance in Acinetobacter baumannii: the molecular epidemic features of an emerging problem in health care facilities.
about
Antimicrobial resistance in Acinetobacter baumannii: From bench to bedsideInfectious disease emergence and global change: thinking systemically in a shrinking worldMolecular epidemiology of multidrug-resistant Acinetobacter baumannii in a tertiary care hospital in Naples, Italy, shows the emergence of a novel epidemic clone.Rapid detection of carbapenem resistance in Acinetobacter baumannii using matrix-assisted laser desorption ionization-time of flight mass spectrometryGES extended-spectrum β-lactamases in Acinetobacter baumannii isolates in Belgium.Effects of a combination of amlodipine and imipenem on 42 clinical isolates of Acinetobacter baumannii obtained from a teaching hospital in Guangzhou, China.Antibiotic use and emerging resistance: how can resource-limited countries turn the tide?Carbapenem-resistant Acinetobacter baumannii from Serbia: revision of CarO classificationCarbapenem-associated multidrug-resistant Acinetobacter baumannii are sensitised by aztreonam in combination with polyamines.Usefulness of phenotypic and genotypic methods for metallo-beta-lactamases detection in carbapenem-resistant Acinetobacter baumannii strainsAcinetobacter baumannii producing OXA-23 detected in the Czech RepublicIdentification of 50 class D β-lactamases and 65 Acinetobacter-derived cephalosporinases in Acinetobacter spp.Antimicrobial active herbal compounds against Acinetobacter baumannii and other pathogens.Hydrolytic mechanism of OXA-58 enzyme, a carbapenem-hydrolyzing class D β-lactamase from Acinetobacter baumannii.Beta-Lactamase Encoded Genes blaTEM and blaCTX Among Acinetobacter baumannii Species Isolated From Medical Devices of Intensive Care Units in Tehran Hospitals.Genotyping of carbapenem resistant Acinetobacter baumannii isolated from tracheal tube discharge of hospitalized patients in intensive care units, Ahvaz, Iran.Acinetobacter baumannii: A Brief Account of Mechanisms of Multidrug Resistance and Current and Future Therapeutic ManagementCharacterization of Oxacillinase and Metallo-β-Lactamas Genes and Molecular Typing of Clinical Isolates of Acinetobacter baumannii in Ahvaz, South-West of Iran.Molecular characterization of acinetobacter isolates collected in intensive care units of six hospitals in Florence, Italy, during a 3-year surveillance program: a population structure analysisEscherichia coli Overexpressing a Baeyer-Villiger Monooxygenase from Acinetobacter radioresistens Becomes Resistant to Imipenem.Detection of class 1 integron in Acinetobacter baumannii isolates collected from nine hospitals in Turkey.Use of the accessory genome for characterization and typing of Acinetobacter baumannii.Evidence of diversity among epidemiologically related carbapenemase-producing Acinetobacter baumannii strains belonging to international clonal lineage II.Acinetobacter spp. Infections in Malaysia: A Review of Antimicrobial Resistance Trends, Mechanisms and Epidemiology.Endemic carbapenem-nonsusceptible Acinetobacter baumannii-calcoaceticus complex in intensive care units of the national referral hospital in Jakarta, Indonesia.In vitro synergistic effect of amlodipine and imipenem on the expression of the AdeABC efflux pump in multidrug-resistant Acinetobacter baumannii.Antibiotic treatment modulates protein components of cytotoxic outer membrane vesicles of multidrug-resistant clinical strain, DU202
P2860
Q27024893-CCD19D6C-2A9E-4B04-B1FD-91E0A51FEDCDQ28678578-129FBB99-09DB-482B-BBFA-BF57830E1B3EQ33769529-C8EFF330-AA5F-4C68-8926-97B42B21BF98Q34168334-B3F930A5-19D0-4839-872E-F89F1EDE84AEQ34290202-2A4B24B8-3B67-4AD4-BA2F-F0F8B01A475EQ35044523-96E9D09C-F1C6-43AB-B447-24885CD90C51Q35205848-4B3D467D-A21C-4A18-9872-0CD39264A4ABQ35590142-94A3C238-E312-443C-AABB-FB5C947FD37DQ36488208-E7307A61-B426-418B-8E7E-41F75EA231C0Q36802076-9FD8E5C4-C750-4168-8A57-067D10D68824Q37025416-DF9B39BF-96DB-42E2-91E6-DDD8BE8633C4Q37544621-63A8B292-392A-4722-A746-2684D12FF673Q38543518-5CA5A0AF-123E-4257-9C98-359F6D07312AQ38795412-D9B3004D-274B-4816-9A4D-4A4AB59E5AF4Q39131859-DB784A27-29F9-43EE-BA26-75DB458E9AA5Q39221224-09412227-045F-4005-A249-4331F249D294Q39279278-FEED9F96-21EF-415F-81EA-3C3091929465Q39459102-0A485C87-86A5-467F-A407-7A21ED14B70AQ39900310-F4047AB2-10C7-4307-AADE-67E9147FFC96Q40439693-16E8F557-4AC5-4A50-B467-C41349C0854CQ41922309-16F0F8D4-D8C6-45F2-9F37-9FBBCC4322B3Q42138698-96474C81-9626-4F8B-95B7-9242D7E2B154Q42597325-40FB11F1-D285-428E-AF1B-29BDAA3767B7Q47194278-69F20713-38C1-48D5-9FDD-0AFBB78635A4Q49526113-BA58B7B1-9A9E-4717-B4FB-64144BCF9FEDQ55262946-1CCB47CA-003D-476D-B7BB-3BAC5F8F7E57Q57751819-6E306D2D-9110-47BC-BFA2-351B468AF8DE
P2860
Carbapenem resistance in Acinetobacter baumannii: the molecular epidemic features of an emerging problem in health care facilities.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Carbapenem resistance in Acine ...... lem in health care facilities.
@en
Carbapenem resistance in Acine ...... lem in health care facilities.
@nl
type
label
Carbapenem resistance in Acine ...... lem in health care facilities.
@en
Carbapenem resistance in Acine ...... lem in health care facilities.
@nl
prefLabel
Carbapenem resistance in Acine ...... lem in health care facilities.
@en
Carbapenem resistance in Acine ...... lem in health care facilities.
@nl
P2093
P1476
Carbapenem resistance in Acine ...... lem in health care facilities.
@en
P2093
Athanassios Tsakris
Federica Tomasone
Maria Giannouli
Maria Triassi
Raffaele Zarrilli
P304
P407
P577
2009-06-01T00:00:00Z